Free Trial

Aptose Biosciences (APTO) News Today

Aptose Biosciences logo

APTO Latest News

Aptose Upgraded to Trade on OTCQB Market
Aptose Provides Corporate Updates
APTOF Aptose Biosciences Inc.
Aptose Announces Auditor Not Standing for Re-Appointment
Aptose Biosciences Inc APTOF
Aptose Biosciences reports FY24 EPS ($36.38) vs. ($227.43) last year
Aptose Biosciences price target raised to $6 from $2 at H.C. Wainwright
Aptose Biosciences trading halted, news pending
Aptose Biosciences approved to escalate dose in Phase 1/2 AML trial
Aptose Biosciences, Inc.: Aptose Announces Reverse Share Split
Aptose Biosciences announces 1-for-30 reverse share split
Aptose Announces Reverse Share Split
Aptose Biosciences files to sell 12.03M shares of common stock for holders
Aptose Biosciences Inc APS
Aptose announces first AML patients dosed in TUSCANY trial
Aptose Biosciences granted extension to regain compliance with Nasdaq
Aptose Announces Positive Decision by Nasdaq Hearings Panel
Promising Potential of Aptose Biosciences in AML Treatment Drives Buy Rating
Aptose Biosciences announces clinical data on tuspetinib
Get Aptose Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for APTO and its competitors with MarketBeat's FREE daily newsletter.

APTO Media Mentions By Week

APTO Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

APTO
News Sentiment

0.80

0.58

Average
Medical
News Sentiment

APTO News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

APTO Articles
This Week

1

1

APTO Articles
Average Week

Get Aptose Biosciences News Delivered to You Automatically

Sign up to receive the latest news and ratings for APTO and its competitors with MarketBeat's FREE daily newsletter.


Related Companies and Tools


This page (NASDAQ:APTO) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners